Related Experiment Video
Updated: May 24, 2026
08:31
A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
Catastrophic late mitral bioprosthetic thrombosis
Hye-Jin Jung1, Bong Gun Song, Seung Hye Heo
1Division of Cardiology, Cardiac and Vascular Center, Department of Medicine, Inje University Seoul Paik Hospital, Seoul, Korea.
Asian Cardiovascular & Thoracic Annals
|February 29, 2012
Summary
Bioprosthetic valve thrombosis is a rare cause of heart valve dysfunction, especially after stopping blood thinners. This case highlights the importance of considering thrombosis in patients with increasing pressure gradients post-anticoagulation.
Area of Science:
- Cardiology
- Cardiac Surgery
- Thrombosis Research
Background:
- Bioprosthetic heart valves offer an alternative to mechanical valves but can be prone to complications.
- Thrombosis of bioprosthetic valves is an uncommon but serious complication, potentially leading to valve dysfunction.
- Anticoagulation management after valve replacement is crucial for preventing thromboembolic events.
Observation:
- A 77-year-old woman presented with symptoms of heart valve dysfunction.
- The patient had undergone bioprosthetic mitral valve replacement and a maze procedure two years prior.
- An increasing transvalvular pressure gradient was noted after the termination of anticoagulation therapy.
Findings:
- The case describes a rare instance of bioprosthetic mitral valve thrombosis.
- The thrombosis was identified as the cause of the observed valve dysfunction.
- This diagnosis was considered when the transvalvular pressure gradient increased after discontinuing anticoagulation.
Implications:
- Clinicians should consider bioprosthetic valve thrombosis in the differential diagnosis of heart valve dysfunction, particularly after anticoagulation cessation.
- Early recognition and management of bioprosthetic valve thrombosis are essential to prevent severe hemodynamic compromise.
- This case underscores the need for vigilance regarding potential complications of bioprosthetic valves, even years after implantation.
Related Concept Videos
01:22Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
01:27Mitral Valve Prolapse I: Introduction
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
01:23Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
01:20Mitral Regurgitation I: Introduction
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
01:22Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.